You are currently on the new version of our website. Access the old version .
BiomedicinesBiomedicines
  • Correction
  • Open Access

27 November 2025

Correction: Colarusso et al. Role of the AIM2 Inflammasome in Cancer: Potential Therapeutic Strategies. Biomedicines 2025, 13, 395

,
,
,
,
,
and
1
Department of Pharmacy (DIFARMA), University of Salerno, 84084 Fisciano, SA, Italy
2
Department of Pharmacy, University of Naples Federico II, 80131 Naples, NA, Italy
*
Author to whom correspondence should be addressed.
This article belongs to the Section Molecular and Translational Medicine
Text Correction
In the original publication [1], as ref. 50 was retracted, it has been replaced with another reference. In this case, the main text has been revised accordingly.
A correction has been made to Section 2, Section 2.4, Paragraph 1:
Original text:
“In an in vitro study, knocking down AIM2 in HCC cells enhanced cell migration, the formation of cell pseudopodium, wound healing, and led to the activation of epithelial–mesenchymal transition (EMT) tumor metastasis, whereas the reintroduction of AIM2 attenuated these effects [50].”
Revised text:
“In addition, AIM2 overexpression inhibited HCC cell proliferation, migration, and invasion while promoting apoptosis and autophagy, effects that were blocked once AIM2 was knocked down [50].”
Reference
As ref. 50 was retracted, it has been replaced with another reference.
Original reference:
“50. Chen, S.L.; Liu, L.L.; Lu, S.X.; Luo, R.Z.; Wang, C.H.; Wang, H.; Cai, S.H.; Yang, X.; Xie, D.; Zhang, C.Z.; et al. HBx-mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis. Mol. Oncol. 2017, 11, 1225–1240”.
Revised reference:
“50. Xie, S.; Wang, C.; Liu, X.; Li, C.; Yu, J.; Ma, S.; Li, Q.; Du, W. Hepatocellular carcinoma and AIM2: Therapeutic potential through regulation of autophagy and macrophage polarization. Immun. Inflamm. Dis. 2024, 12, e70002”.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Colarusso, C.; Terlizzi, M.; Di Caprio, S.; Falanga, A.; D’Andria, E.; d’Emmanuele di Villa Bianca, R.; Sorrentino, R. Role of the AIM2 Inflammasome in Cancer: Potential Therapeutic Strategies. Biomedicines 2025, 13, 395. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.